New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 29, 2012
08:15 EDTTKMRTekmira Pharmaceuticals acquires worldwide license to novel RNAi Technology
Tekmira Pharmaceuticals announced that it has obtained a worldwide, non-exclusive license to a novel RNAi payload technology called Unlocked Nucleobase Analog, or UNA, from Marina Biotech, for the development of RNAi therapeutics. UNA technology can be used in the development of RNAi therapeutics, which treat disease by silencing specific disease causing genes. UNAs can be incorporated into RNAi drugs and have the potential to improve them by increasing their stability and reducing off-target effects.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for TKMR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use